[1]
B. K. Malhotra, PhD, G. L. Schoenhard, PhD, A. W. de Kater, PhD, and N. Friedmann, PhD, MD, “The pharmacokinetics of oxycodone and its metabolites following single oral doses of Remoxy®, an abuse-deterrent formulation of extended-release oxycodone, in patients with hepatic or renal impairment”, J of Opioid Management, vol. 11, no. 2, pp. 157–169, Mar. 2015.